65 related articles for article (PubMed ID: 1369721)
1. Naftidrofuryl after acute stroke: a review and a hypothesis.
Steiner TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S58-61. PubMed ID: 1369721
[TBL] [Abstract][Full Text] [Related]
2. Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
Steiner TJ
Vasa Suppl; 1988; 24():44-7. PubMed ID: 3062824
[No Abstract] [Full Text] [Related]
3. Naftidrofuryl in the treatment of subacute stroke.
Capon A; Lehert P; Opsomer L
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S62-6. PubMed ID: 1369722
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind controlled trial of naftidrofuryl in acute stroke.
Gray CS; French JM; Venables GS; Cartlidge NE; James OF; Bates D
Age Ageing; 1990 Nov; 19(6):356-63. PubMed ID: 2285001
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of drugs in peripheral vascular disease and stroke.
Drummond M; Davies L
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S4-7. PubMed ID: 7517476
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological therapy for acute stroke: the future.
Panayiotou BN; Fotherby MD
Br J Clin Pract; 1995; 49(6):314-7. PubMed ID: 8554956
[TBL] [Abstract][Full Text] [Related]
7. New approach to treatment of recent stroke.
Admani AK
Br Med J; 1978 Dec; 2(6153):1678-9. PubMed ID: 367511
[TBL] [Abstract][Full Text] [Related]
8. Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ischemic stroke.
Kobayashi S; Yamaguchi S; Katsube T; Okada K; Kitani M; Murao M; Tsunematsu T
Arzneimittelforschung; 1984; 34(11):1580-3. PubMed ID: 6543134
[TBL] [Abstract][Full Text] [Related]
9. Towards a model stroke trial. The single-centre naftidrofuryl study.
Steiner TJ; Clifford Rose F
Neuroepidemiology; 1986; 5(3):121-47. PubMed ID: 3537823
[TBL] [Abstract][Full Text] [Related]
10. Naftidrofuryl (Praxilene).
Drug Ther Bull; 1988 Apr; 26(7):25-7. PubMed ID: 3286179
[No Abstract] [Full Text] [Related]
11. Important new treatments for acute ischaemic stroke?
Sandercock P
Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1224-5. PubMed ID: 3120954
[No Abstract] [Full Text] [Related]
12. Double-blind evaluation of naftidrofuryl in treating elderly confused hospitalised patients.
Cox JR
Gerontol Clin (Basel); 1975; 17(3):160-7. PubMed ID: 1102394
[TBL] [Abstract][Full Text] [Related]
13. [Heparin during acute ischemic stroke. Present data and clinical situation].
Daffertshofer M; Grips E; Dempfle CE; Hennerici M
Nervenarzt; 2003 Apr; 74(4):307-19. PubMed ID: 12707700
[TBL] [Abstract][Full Text] [Related]
14. Rationale for testing thrombolysis in acute ischaemic stroke. MAST Group.
Hommel M; Cornu C
Clin Trials Metaanal; 1993 Nov; 28(6):345-56. PubMed ID: 10172266
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. New approach to treatment of recent stroke?
Perkin GD
Br Med J; 1979 May; 1(6173):1283. PubMed ID: 378323
[No Abstract] [Full Text] [Related]
17. Economic burden of stroke and the evaluation of new therapies.
Kaste M; Fogelholm R; Rissanen A
Public Health; 1998 Mar; 112(2):103-12. PubMed ID: 9581452
[TBL] [Abstract][Full Text] [Related]
18. Hospital disposition after stroke in a national survey of acute cerebrovascular diseases in Israel.
Treger I; Ring H; Schwartz R; Tsabari R; Bornstein NM; Tanne D;
Arch Phys Med Rehabil; 2008 Mar; 89(3):435-40. PubMed ID: 18295620
[TBL] [Abstract][Full Text] [Related]
19. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
[TBL] [Abstract][Full Text] [Related]
20. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
Wiernsperger NF
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]